Metformin has been reported to improve glucose tolerance, ameliorate insulin resistance, and reduce obesity by increasing TUDCA levels, while GUDCA has also been shown to improve insulin sensitivity in diabetic populations [9, 34]. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.